Question from Deputy Ken O'Flynn - PQ 36572-26
Deputy O'Flynn asked if a classification framework distinguishing medically necessary from elective or quality-of-life procedures will be established.
- Published date:
- :
Browse and read HSE's latest publications, which include strategic plans, reports, official policies and codes, Parliamentary Question (PQ) responses, and board meeting minutes.
Deputy O'Flynn asked if a classification framework distinguishing medically necessary from elective or quality-of-life procedures will be established.
Deputy O'Flynn asked about the number of medicines currently awaiting a commercial proposal from a marketing authorisation holder.
Deputy O'Flynn asked if the HSE maintains any internal monitoring system tracking delays attributable to marketing authorisation holders. Read the HSE response.
Deputy O'Flynn asked if a risk assessment has been undertaken regarding the absence of national audit and monitoring systems in certain healthcare pathways.
Deputy Callaghan asked about the number of people currently waiting to attend cancer genetics services at Crumlin Children's Hospital. Read the HSE response.
Deputy O'Flynn asked if obesity-related disease expenditure is identifiable within the HSE budgeting process. Read the HSE response.
Deputy O'Flynn asked about the average time taken to resolve and reimburse corrected pharmacy claims. Read the HSE response.
Deputy O'Flynn asked about the administrative or submission errors resulting in rejected or unpaid pharmacy claims. Read the HSE response.
Deputy Callaghan asked about the optimum staffing allocation in the cancer genetics department in Crumlin Children's Hospital. Read the HSE response.
Deputy O'Flynn asked for the number of pharmacy claims rejected by the Primary Care Reimbursement Service in 2024 and 2025. Read the HSE response.